Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who are already receiving regular care at one of the trial sites, or who have been separately invited to take part in the study.
- People who have read the study information and signed a consent form agreeing to participate.
Who may not be able to join:
- People who have a cognitive impairment (such as difficulties with thinking, memory, or understanding).
- People who are not able to understand spoken or written information in Swedish or English.
- People who have another serious illness or a terminal (end-of-life) condition.
- People who are not able to give their own informed consent to participate.
- People who are not able to stand upright with their eyes closed and maintain their balance without any assistance or support.
- People who experience claustrophobia (fear of enclosed or confined spaces).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Andreea Valdman, MD, Neko Health AB
Phone: 0703169040
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity for detection of lesions requiring excision in comparison to visual inspection; Difference in body metrics between full-body 3D photography and traditional measurements; Sensitivity in detection of dermatological conditions with 2D images from full-body photography; Sensitivity in detection of new or significantly changed lesions, from macroscopic images using 2D and 3D full-body photography.; Correlation between thermal gradient in hands and/or feet with diagnosis of peripheral arterial disease or Raynaud's phenomenon
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.